Evening Primrose Oil
Also known as: EPO, Oenothera biennis oil, gamma-linolenic acid oil, GLA oil
Effective Dosage
1000–2000 mg daily (oral or vaginal depending on use)
What the Science Says
Evening primrose oil (EPO) is a plant-derived oil extracted from the seeds of Oenothera biennis, and it is rich in gamma-linolenic acid (GLA), an omega-6 fatty acid with anti-inflammatory properties. Clinical trials show it can meaningfully reduce pain in diabetic neuropathy at doses of 1000–2000 mg daily, and vaginal application has been shown to aid cervical ripening in late pregnancy and reduce the need for labor induction drugs. When combined with fish oil in breast cancer patients undergoing chemotherapy, it helped lower inflammatory markers like IL-6 and improved fatty acid profiles over 12 weeks.
What It Doesn't Do
Not proven to relieve menopausal hot flashes on its own — women use it widely for this, but the provided studies don't support that claim. No solid evidence it treats eczema in children; a systematic review found the evidence remains limited. Won't replace standard diabetic neuropathy medications — it may complement them, but studies are small and short. Not a cancer treatment — the anti-inflammatory benefit was seen alongside chemotherapy, not as a standalone therapy.
Evidence-Based Benefits
EPO shows preliminary evidence for reducing pain in diabetic neuropathy, with 1000 mg twice daily significantly reducing VAS and NTSS-6 scores versus placebo in a small RCT (PMID: 40418820). Vaginally administered EPO appears effective for cervical ripening in term pregnancies, improving Bishop scores and reducing need for labor induction (PMID: 38377980), and outperformed misoprostol for pre-surgical cervical dilation (PMID: 37102338). When combined with fish oil, EPO supplementation reduced IL-6 levels and improved PUFA status in breast cancer patients undergoing chemotherapy (PMID: 37081029), though EPO's independent contribution is unclear.
Weak EvidenceEffective at: 1000-2000 mg daily (oral or vaginal depending on indication); No universally established dose across all uses
Source: auto-research
Absorption & Bioavailability
Unknown from provided studies — oral and vaginal routes are both used clinically, but no pharmacokinetic absorption data was reported in the provided papers
Red Flags to Watch For
- Vaginal use during pregnancy should only be done under medical supervision — it can accelerate labor
- Most clinical trials are small (under 50 participants per group) and short-term (4–12 weeks), limiting confidence in results
- Combined with fish oil in the cancer study — hard to isolate EPO's specific contribution to outcomes
- Widely used for menopause symptoms despite no strong evidence from the provided studies supporting this use
- Animal study data (diabetic rats) cannot be directly applied to humans without further clinical validation
Research Sources
- PubMed
- NIH DSLD
This information is for educational purposes only and is not medical advice. Always consult a healthcare professional before starting any supplement regimen. Last updated: 2026-04-06